220 related articles for article (PubMed ID: 36874080)
1. The effect of perioperative blood transfusion on survival after renal cell carcinoma nephrectomy: A systematic review and meta-analysis.
Liu Y; Deng X; Wen Z; Huang J; Wang C; Chen C; Yang X
Front Oncol; 2023; 13():1092734. PubMed ID: 36874080
[TBL] [Abstract][Full Text] [Related]
2. Impact of perioperative blood transfusion on oncologic outcomes in patients with nonmetastatic renal cell carcinoma treated with curative nephrectomy: A retrospective analysis of a large, single-institutional cohort.
Seon DY; Kwak C; Kim HH; Ku JH; Kim HS
Investig Clin Urol; 2020 Mar; 61(2):136-145. PubMed ID: 32158964
[TBL] [Abstract][Full Text] [Related]
3. Perioperative blood transfusion adversely affects prognosis after nephrectomy for renal cell carcinoma.
Abu-Ghanem Y; Zilberman DE; Dotan Z; Kaver I; Ramon J
Urol Oncol; 2018 Jan; 36(1):12.e15-12.e20. PubMed ID: 28993059
[TBL] [Abstract][Full Text] [Related]
4. Impact of perioperative blood transfusion on prognosis after nephrectomy in patients with renal cell carcinoma: A meta-analysis and systematic review.
Xu J; Bai J; Pan H; Zhou Z
Medicine (Baltimore); 2024 Apr; 103(14):e37646. PubMed ID: 38579099
[TBL] [Abstract][Full Text] [Related]
5. Perioperative blood transfusion affects oncologic outcomes after nephrectomy for renal cell carcinoma: A systematic review and meta-analysis.
Iwata T; Kimura S; Foerster B; Abufaraj M; Karakiewicz PI; Preisser F; Nasu Y; Shariat SF
Urol Oncol; 2019 Apr; 37(4):273-281. PubMed ID: 30737159
[TBL] [Abstract][Full Text] [Related]
6. Comparison of oncologic outcomes between partial and radical nephrectomy for localized renal cell carcinoma: A systematic review and meta-analysis.
Gu L; Ma X; Li H; Chen L; Xie Y; Li X; Gao Y; Zhang Y; Zhang X
Surg Oncol; 2016 Dec; 25(4):385-393. PubMed ID: 27916170
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the long-term follow-up and perioperative outcomes of partial nephrectomy and radical nephrectomy for 4 cm to 7 cm renal cell carcinoma: a systematic review and meta-analysis.
Jiang YL; Peng CX; Wang HZ; Qian LJ
BMC Urol; 2019 Jun; 19(1):48. PubMed ID: 31174522
[TBL] [Abstract][Full Text] [Related]
8. A meta-analysis for comparison of partial nephrectomy
Liu H; Kong QF; Li J; Wu YQ; Pan KH; Xu B; Wang YL; Chen M
Transl Androl Urol; 2021 Mar; 10(3):1170-1178. PubMed ID: 33850752
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative allogeneic blood transfusion is associated with adverse oncological outcomes in patients with surgically treated non-metastatic clear cell renal cell carcinoma.
Kang HW; Seo SP; Kim WT; Yun SJ; Lee SC; Kim WJ; Hwang EC; Kang SH; Hong SH; Chung J; Kwon TG; Kim HH; Kwak C; Byun SS; Kim YJ;
Int J Clin Oncol; 2020 Aug; 25(8):1551-1561. PubMed ID: 32504136
[TBL] [Abstract][Full Text] [Related]
10. Partial nephrectomy provides equivalent oncologic outcomes and better renal function preservation than radical nephrectomy for pathological T3a renal cell carcinoma: A meta-analysis.
Deng H; Fan Y; Yuan F; Wang L; Hong Z; Zhan J; Zhang W
Int Braz J Urol; 2021; 47(1):46-60. PubMed ID: 32271510
[TBL] [Abstract][Full Text] [Related]
11. Prognostic nutritional index and prognosis in renal cell carcinoma: A systematic review and meta-analysis.
Kim SI; Kim SJ; Kim SJ; Cho DS
Urol Oncol; 2021 Oct; 39(10):623-630. PubMed ID: 34253447
[TBL] [Abstract][Full Text] [Related]
12. Comparison of prognosis between patients undergoing radical nephrectomy versus partial nephrectomy for renal cell carcinoma ≤7 cm T3aN0/xM0: Survival benefit is biased toward partial nephrectomy.
Liu S; Feng C; Liu C; Wang Z
Cancer Med; 2021 Dec; 10(24):8909-8923. PubMed ID: 34779154
[TBL] [Abstract][Full Text] [Related]
13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
14. Perioperative Allogenic Blood Transfusion in Renal Cell Carcinoma: Risk Factors and Effect on Long-term Outcomes.
Soria F; de Martino M; Leitner CV; Moschini M; Shariat SF; Klatte T
Clin Genitourin Cancer; 2017 Jun; 15(3):e421-e427. PubMed ID: 28089722
[TBL] [Abstract][Full Text] [Related]
15. Association between Allogeneic or Autologous Blood Transfusion and Survival in Patients after Radical Prostatectomy: A Systematic Review and Meta-Analysis.
Li SL; Ye Y; Yuan XH
PLoS One; 2017; 12(1):e0171081. PubMed ID: 28135341
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Diabetes Mellitus on Renal Cell Carcinoma Prognosis: A Meta-Analysis of Cohort Studies.
Chen L; Li H; Gu L; Ma X; Li X; Gao Y; Zhang Y; Shen D; Fan Y; Wang B; Bao X; Zhang X
Medicine (Baltimore); 2015 Jul; 94(26):e1055. PubMed ID: 26131819
[TBL] [Abstract][Full Text] [Related]
17. Partial nephrectomy versus radical nephrectomy for large (≥ 7 cm) renal tumors: A systematic review and meta-analysis.
Deng W; Chen L; Wang Y; Liu X; Wang G; Fu B
Urol Oncol; 2019 Apr; 37(4):263-272. PubMed ID: 30704957
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Implication and Survival Outcomes of Perioperative Blood Transfusion on Urological Malignancies Undergoing Radical Surgical Intervention.
Mallick S; Mallik M; Chowdhury PS
Iran J Pathol; 2023; 18(1):33-48. PubMed ID: 37383156
[TBL] [Abstract][Full Text] [Related]
19. The impact of perioperative blood transfusion on survival after nephrectomy for non-metastatic renal cell carcinoma (RCC).
Linder BJ; Thompson RH; Leibovich BC; Cheville JC; Lohse CM; Gastineau DA; Boorjian SA
BJU Int; 2014 Sep; 114(3):368-74. PubMed ID: 24471825
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of the Glasgow Prognostic Score in renal cell carcinoma: a meta-analysis.
Shim SR; Kim SJ; Kim SI; Cho DS
World J Urol; 2017 May; 35(5):771-780. PubMed ID: 27665441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
